Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

The Journal of Clinical Investigation
David J DiLilloJeffrey V Ravetch

Abstract

In vivo protection by antimicrobial neutralizing Abs can require the contribution of effector functions mediated by Fc-Fcγ receptor (Fc-FcγR) interactions for optimal efficacy. In influenza, broadly neutralizing anti-hemagglutinin (anti-HA) stalk mAbs require Fc-FcγR interactions to mediate in vivo protection, but strain-specific anti-HA head mAbs do not. Whether this rule applies only to anti-stalk Abs or is applicable to any broadly neutralizing Ab (bNAb) against influenza is unknown. Here, we characterized the contribution of Fc-FcγR interactions during in vivo protection for a panel of 13 anti-HA mAbs, including bNAbs and non-neutralizing Abs, against both the stalk and head domains. All classes of broadly binding anti-HA mAbs required Fc-FcγR interactions to provide protection in vivo, including those mAbs that bind the HA head and those that do not neutralize virus in vitro. Further, a broadly neutralizing anti-neuraminidase (anti-NA) mAb also required FcγRs to provide protection in vivo, but a strain-specific anti-NA mAb did not. Thus, these findings suggest that the breadth of reactivity of anti-influenza Abs, regardless of their epitope, necessitates interactions with FcγRs on effector cell populations to mediate in vi...Continue Reading

References

Dec 3, 2005·Science·Falk Nimmerjahn, Jeffrey V Ravetch
Apr 15, 2010·The Journal of Clinical Investigation·Davide CortiAntonio Lanzavecchia
Dec 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Karim El BakkouriXavier Saelens
Aug 13, 2011·Science·Taia T Wang, Peter Palese
Apr 5, 2012·Proceedings of the National Academy of Sciences of the United States of America·Patrick SmithJeffrey V Ravetch
Jan 19, 2013·Annual Review of Medicine·Natalie Pica, Peter Palese
Jul 22, 2014·Nature Immunology·Andrew PinceticJeffrey V Ravetch
Feb 28, 2015·Nature Reviews. Drug Discovery·Florian Krammer, Peter Palese
Aug 19, 2015·The Journal of Experimental Medicine·Stylianos BournazosJeffrey V Ravetch

❮ Previous
Next ❯

Citations

Jun 28, 2016·Current Opinion in Immunology·Antonio LanzavecchiaDavide Corti
Oct 21, 2016·Current Opinion in Pharmacology·Lieve NaesensEvelien Vanderlinden
Sep 21, 2016·Proceedings of the National Academy of Sciences of the United States of America·Paul E LeonGene S Tan
Oct 19, 2016·Trends in Microbiology·Boopathy RamakrishnanRam Sasisekharan
Oct 21, 2016·Trends in Molecular Medicine·Bronwyn M Gunn, Galit Alter
Jan 14, 2017·AIDS Research and Human Retroviruses·George K LewisAndrés Finzi
Mar 24, 2017·Human Vaccines & Immunotherapeutics·Sinthujan JegaskandaStephen J Kent
Nov 18, 2017·Viral Immunology·Amber M Smith, Victor C Huber
Jan 23, 2018·Viral Immunology·Meghan O AltmanJonathan W Yewdell
Dec 7, 2017·Frontiers in Immunology·Luzia M MayrChristiane Moog
May 17, 2018·Physiological Reviews·Lee J QuintonJoseph P Mizgerd
Mar 3, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Vinayak BrahmakshatriyaSusan L Swain
Sep 7, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jad MaamaryJeffrey V Ravetch
Oct 31, 2017·Nature Reviews. Microbiology·Velislava N Petrova, Colin A Russell
Jun 4, 2018·The Journal of Infectious Diseases·Hillary A VandervenUNKNOWN INSIGHT FLU005 Pilot Study Writing Group
Jul 10, 2018·Human Vaccines & Immunotherapeutics·Rajeev Rudraraju, Kanta Subbarao
Jul 26, 2018·Vaccines·Rory D de VriesMathilde Richard
Aug 24, 2018·PLoS Pathogens·Philipp A IlinykhAlexander Bukreyev
Aug 8, 2018·American Journal of Epidemiology·Suzanne L Epstein
Aug 28, 2018·Expert Review of Vaccines·Federica SiccaAnke Huckriede
Dec 20, 2017·Proceedings of the National Academy of Sciences of the United States of America·Donald D RaymondStephen C Harrison
Oct 14, 2018·The Journal of Biological Chemistry·Guozhang ZouTongzhong Ju
Jan 8, 2019·Human Vaccines & Immunotherapeutics·E GianchecchiE Montomoli
Feb 21, 2019·Proceedings of the National Academy of Sciences of the United States of America·Yung-Chieh TsengChe Ma

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.